Recurrent nAMD after discontinuation of VEGF inhibitors managed in a treat-and-extend regimen
Aslanis et al
Ophthalmology Retina, published online March 2021
Sign up to keep reading
Create a free Member account at NZ Optics to read this article and more.
- Read all Member articles
- Full digital magazine archive
- Early access to new articles







